J9178 Injection, epirubicin hcl, 2 milligrams
Also known as: epirubicin, Ellence
Intravenous injection of epirubicin hydrochloride, an anthracycline topoisomerase II inhibitor, dosed per 2 milligrams.
In Plain Language
red chemotherapy drug; DNA-damaging cancer drug
Clinical Context
Used for breast cancer and other cancers as component of combination chemotherapy regimens.
RVU Information
CPT J9178 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9178?
CPT J9178 (Injection, epirubicin hcl, 2 milligrams) is a J Codes (Drugs) code. Intravenous injection of epirubicin hydrochloride, an anthracycline topoisomerase II inhibitor, dosed per 2 milligrams.
How is J9178 administered?
CPT J9178 is administered by a healthcare provider, typically via injection or infusion. Used for breast cancer and other cancers as component of combination chemotherapy regimens. It is used by Oncology, Medical Oncology.
When is CPT J9178 used?
Used for breast cancer and other cancers as component of combination chemotherapy regimens.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.